Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00699309 · ClinicalTrials.gov registry record
A Clinical Investigation of the Taperloc® Microplasty™ Hip System
A clinical trial, sponsored by Biomet Orthopedics.
- Completed
- Registry status
- 98
- Enrollment target
NCT00699309: Completed study, sponsored by Biomet Orthopedics.
NCT00699309 is a clinical trial that has completed, run by Biomet Orthopedics. The registered enrollment target is 98 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00699309 has completed, sponsored by Biomet Orthopedics.
- COMPLETED
- Registry status
- 98 participants
- Enrollment target
Study Summary
The purpose of this prospective clinical data-collection is to document the performance and clinical outcomes of the Taperloc® Microplasty™ Hip System.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2005-08 |
| Est. Completion | 2013-03 |
What the finished NCT00699309 record still lists
NCT00699309 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 98 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00699309 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00699309 about?
NCT00699309 is a clinical study titled "A Clinical Investigation of the Taperloc® Microplasty™ Hip System". The purpose of this prospective clinical data-collection is to document the performance and clinical outcomes of the Taperloc® Microplasty™ Hip System.
What is the current status of trial NCT00699309?
This trial is currently completed. The enrollment target is 98 participants. The study started on 2005-08. Estimated completion is 2013-03.
Who is sponsoring clinical trial NCT00699309?
This trial is sponsored by Biomet Orthopedics, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02926729 · 98 participants · NA
Real-Time Assessment Of Breast Cancer Lumpectomy Specimen Margins With Nonlinear Microscopy
- NCT03382977 · 98 participants · Phase 1
Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects
- NCT04577014 · 98 participants · Phase 1
Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma
- NCT04817618 · 98 participants · Phase 3
Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia